TGACC reviews use of GLP-1 receptor agonists as meal replacements or supplements
Australia
Apr 14, 2025
The Therapeutic Goods Advertising Consultative Committee (TGACC) met in Sydney on Thursday 6 March 2025. Members discussed concerns about foods and supplements claiming to complement GLP-1 receptor agonist (GLP-1 RA) use, such as meal replacements or supplements. Members also discussed the impact of economic factors on vitamin supplement consumption. Concerns were raised about the advertising of these products, considering health implications for consumers who substitute fresh fruits and vegetables with supplements.
For further information (in English), click on the Link